Trade Zynerba Pharmaceuticals, Inc. - ZYNE CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.25 |
| Open | 1.25 |
| 1-Year Change | 73.61% |
| Day's Range | 1.25 - 1.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 10, 2023 | 1.29 | 0.05 | 4.03% | 1.24 | 1.31 | 1.24 |
| Oct 9, 2023 | 1.25 | 0.04 | 3.31% | 1.21 | 1.26 | 1.21 |
| Oct 6, 2023 | 1.25 | 0.05 | 4.17% | 1.20 | 1.25 | 1.20 |
| Oct 5, 2023 | 1.24 | 0.06 | 5.08% | 1.18 | 1.24 | 1.18 |
| Oct 4, 2023 | 1.19 | -0.04 | -3.25% | 1.23 | 1.24 | 1.16 |
| Oct 3, 2023 | 1.24 | 0.00 | 0.00% | 1.24 | 1.24 | 1.21 |
| Oct 2, 2023 | 1.24 | -0.01 | -0.80% | 1.25 | 1.25 | 1.23 |
| Sep 29, 2023 | 1.25 | -0.01 | -0.79% | 1.26 | 1.26 | 1.24 |
| Sep 28, 2023 | 1.26 | 0.01 | 0.80% | 1.25 | 1.26 | 1.25 |
| Sep 27, 2023 | 1.25 | 0.01 | 0.81% | 1.24 | 1.28 | 1.24 |
| Sep 26, 2023 | 1.26 | -0.04 | -3.08% | 1.30 | 1.31 | 1.25 |
| Sep 25, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.30 | 1.30 |
| Sep 22, 2023 | 1.31 | 0.01 | 0.77% | 1.30 | 1.32 | 1.30 |
| Sep 21, 2023 | 1.30 | -0.01 | -0.76% | 1.31 | 1.33 | 1.29 |
| Sep 20, 2023 | 1.33 | 0.03 | 2.31% | 1.30 | 1.34 | 1.30 |
| Sep 19, 2023 | 1.31 | 0.00 | 0.00% | 1.31 | 1.33 | 1.31 |
| Sep 18, 2023 | 1.31 | -0.02 | -1.50% | 1.33 | 1.34 | 1.31 |
| Sep 15, 2023 | 1.36 | 0.05 | 3.82% | 1.31 | 1.37 | 1.31 |
| Sep 14, 2023 | 1.32 | 0.02 | 1.54% | 1.30 | 1.32 | 1.30 |
| Sep 13, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.33 | 1.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.| Industry: | Biotechnology & Medical Research (NEC) |
80 W. Lancaster Avenue
Suite 300
DEVON
PENNSYLVANIA 19333
US
News
Bank of England preview: possible rate cut in summer?
The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.
12:39, 8 May 2024
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com